Clinical Psychology Science and Practice
January 1, 2004
Scott R. Bishop, Mark A. Lau, Shauna L. Shapiro et al.
6,266 citations
Mindfulness has attracted considerable interest as a way to reduce cognitive vulnerability to stress and emotional distress, but it has not been defined operationally. Recent consensus meetings produced a two-component model of mindfulness, specifying each component in terms of specific behaviors, experiential manifestations, and psychological processes. The paper addresses temporal stability and situational specificity, speculates on the conceptual and operational distinctiveness of mindfulness, and discusses implications for instrument development and measurement.
Annual Review of Psychology
September 14, 2022
Linda E. Carlson
50 citations
People diagnosed with and treated for cancer commonly experience distress, anxiety, depression, fear of recurrence, and caregiver burden, along with fatigue, pain, and sleep disturbance. This review covers psychological reactions across the disease continuum and evaluates interventions such as acceptance-based and mindfulness therapies, mind-body approaches, meaning-based therapies for advanced disease, and psychedelic therapy. It also identifies methodological shortcomings in the evidence base, offers design recommendations, and discusses future directions including pragmatic research designs, digital health interventions, and implementation science.
Christopher P. Albertyn, Jeremie Richard, Ron Joseph Shore et al.
preprint
Demoralization syndrome affects about one in five Canadians with advanced cancer, marked by helplessness, hopelessness, and loss of meaning, and is linked to a greater desire for hastened death and worse outcomes, but it is underrecognized and undertreated. Pharmacological treatments fail to address its existential roots, and psychosocial therapies are underfunded and not universally effective. Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) combines mindfulness training with psilocybin's neuroplastic effects, but its traditional one-on-one delivery limits scalability. The authors argue that group-based MB-PAT could bridge this gap by leveraging existing group therapy infrastructure and therapist familiarity with mindfulness, offering a scalable, equity-focused model for publicly funded Canadian oncology. The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) is highlighted as a key initiative to generate evidence and capacity.